CXCL8 and COVID-19: One of the latest uses that has been tested for the CBD extract was developed in an in vitro model of lung epithelial cells infected by COVID-19, at a concentration of 9.5 to 10.9 μM, which managed to significantly reduce the production of IL- 6 and IL-8 without generating significant cytotoxicity, resulting in even better action than that of dexamethasone, which requires a dose greater than 12 μM [55].